Married couples share the risk of diabetes: Study

Agencies
May 24, 2018

London, May 24: Your partner’s body mass index (BMI) can predict your risk of developing diabetes, according to a which found study has found that men are particularly more prone to developing the metabolic disease if their wife obese.

Researchers from University of Copenhagen and Aarhus University in Denmark examined data from 3,649 men and 3,478 women in the UK.

On a global scale, 422 million adults have diabetes according to World Health Organisation (WHO), and it is estimated to cause 1.5 million deaths.

“We have discovered that you can predict a person’s risk of developing type 2 diabetes based on his or her partner’s BMI. This means that you can tell whether a person has a heightened risk or not on the basis of the partner’s BMI,” said Jannie Nielsen, which has been published in the scientific journal Diabetologia.

From other studies the researchers knew that spouses are often similar in terms of body weight, among other things because people often marry someone similar to themselves and often share dietary and exercise habits when living together.

Therefore, the researchers also examined whether the heightened risk of developing type 2 diabetes of an obese woman, for example, was merely a result of her own body weight. Here the researchers found a difference between the two sexes.

“If we adjusted for the women’s own weight, they did not have a heightened risk of developing type 2 diabetes as a result of their husband’s BMI. But even when we adjusted for the weight in men, they had a heightened risk,” said Nielsen.

A man, whose wife had a BMI of 30, had a 21 per cent higher risk of developing diabetes than men whose wives had a BMI of 25 – regardless of the man’s own BMI.

The researchers have not examined why only the men still had a heightened risk after own weight adjustment. They do have a theory, though, which involves who is in charge of the household.

“We believe it is because women generally decide what we eat at home. That is, women have greater influence on their spouse’s dietary habits than men do,” Nielsen said, referring to a previous study, which showed that women more often than men are responsible for doing the household’s cooking and shopping.

Diabetes can cause complications and serious sequelae such as damage to the heart, kidneys and eyes. According to the Danish Diabetes Association, 35 per cent experience complications by the time they are diagnosed with diabetes. Therefore, early detection is vital.

“The earlier a disease is detected, the higher the potential for successful prevention and treatment. We know that type 2 diabetes can be prevented or postponed, reducing the number of years that patients have to live with the disease. Just as related complications can be postponed through early detection,” said Nielsen.

If type 2 diabetes is detected at an early stage, medical treatment can be postponed, and instead the patient can begin with lifestyle changes such as eating a healthy diet and doing more physical exercise.

Based on the study, Nielsen believes that early detection of type 2 diabetes can be improved if we change our approach to the disease.

“Our approach to type 2 diabetes should not focus on the individual, but instead on, for example, the entire household. If a woman has a heightened risk, there is a strong probability that it is shared by her husband,” she said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 19,2020

Researchers have found that patients with peripheral artery disease or stroke were less likely to receive recommended treatments to prevent heart attack than those with coronary artery disease. All three are types of atherosclerotic cardiovascular disease.

Depending on the location of the blockage, atherosclerosis increases the risk for three serious conditions: coronary artery disease, stroke and peripheral artery disease.

"Our study highlights the need for public health campaigns to direct equal attention to all three major forms of atherosclerotic cardiovascular disease," said senior study author Erin Michos from the Johns Hopkins University in the US.

"We need to generate awareness among both clinicians and patients that all of these diseases should be treated with aggressive secondary preventive medications, including aspirin and statins, regardless of whether people have heart disease or not," Michos added.

Since atherosclerosis can affect arteries in more than one part of the body, medical guidelines are to treat coronary artery disease, stroke and peripheral artery disease similarly with lifestyle changes and medication, including statins to lower cholesterol levels and aspirin to prevent blood clots.

Lifestyle changes include eating a healthy diet, being physically active, quitting smoking, controlling high cholesterol, controlling high blood pressure, treating high blood sugar and losing weight.

What was unclear was if people with stroke and peripheral artery disease received the same treatments prescribed for those with coronary artery disease.

This study compared more than 14,000 US adults enrolled in the 2006-2015 Medical Expenditure Panel Survey, a national survey of patient-reported health outcomes and conditions, and health care use and expenses.

Slightly more than half of the patients were men, the average age was 65, and all had either coronary artery disease, stroke or peripheral artery disease.

These individuals were the representative of nearly 16 million US adults living with one of the three forms of atherosclerotic cardiovascular disease.

Compared to participants with coronary artery disease, participants with peripheral artery disease were twice more likely to report no statin use and three times more likely to report no aspirin use.

Additionally, people with peripheral artery disease had the highest, annual, total out-of-pocket expenditures among the three atherosclerotic conditions.

The findings showed that participants with stroke were more than twice as likely to report no statin or aspirin use.

Moreover, those with stroke were more likely to report poor patient-provider communication, poor health care satisfaction and more emergency room visits.

"Our study highlights a missed opportunity for implementing life-saving preventive medications among these high-risk individuals," Michos said.

The study was presented in the virtual conference at the American Heart Association's Quality of Care & Outcomes Research Scientific Sessions 2020.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 2,2020

London, Jul 2: The World Health Organisation says smoking is linked to a higher risk of severe illness and death from the coronavirus in hospitalised patients, although it was unable to specify exactly how much greater those risks might be.

In a scientific brief published this week, the U.N. health agency reviewed 34 published studies on the association between smoking and Covid-19, including the probability of infection, hospitalisation, severity of disease and death.

WHO noted that smokers represent up to 18% of hospitalised coronavirus patients and that there appeared to be a significant link between whether or not patients smoked and the severity of disease they suffered, the type of hospital interventions required and patients' risk of dying.

In April, French researchers released a small study suggesting smokers were at less risk of catching Covid-19 and planned to test nicotine patches on patients and health workers — but their findings were questioned by many scientists at the time who cited the lack of definitive data.

WHO says "the available evidence suggests that smoking is associated with increased severity of disease and death in hospitalized Covid-19 patients. It recommends that smokers quit.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 26,2020

Tedros Adhanom Ghebreyesus, the World Health Organisation's (WHO) Director-General, said that a clinical trial of hydroxychloroquine (HCQ) on COVID-19 patients has come to "a temporary pause", while the safety data of the the anti-malaria drug was being reviewed.

According to the WHO chief, The Lancet medical journal on May 22 had published an observational study on HCQ and chloroquine and its effects on COVID-19 patients that have been hospitalized, reports Xinhua news agency.

The authors of the study reported that among patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate.

"The Executive Group of the Solidarity Trial, representing 10 of the participating countries, met on Saturday (May 23) and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally," Tedros said in a virtual press conference on Monday.

The review will consider data collected so far in the Solidarity Trial and in particular robust randomized available data, to adequately evaluate the potential benefits and harms from this drug, he said.

"The Executive Group has implemented a temporary pause of the HCQ arm within the Solidarity Trial while the safety data is reviewed by the Data Safety Monitoring Board. The other arms of the trial are continuing," Tedros added.

WHO initiated the Solidarity Trial, a plan to evaluate the safety and efficacy of four drugs and drug combinations against COVID-19 more than two months ago, which include HCQ.

According to the WHO, over 400 hospitals in 35 countries are actively recruiting patients and nearly 3,500 patients have been enrolled from 17 countries under the Solidarity Trial.

Tedros added that the safety concern over the drug related only to the use of HCQ and chloroquine in COVID-19, and "these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria".

"WHO will provide further updates as we know more," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.